Comparative Pharmacology
Head-to-head clinical analysis: LEVOTHYROXINE versus THYQUIDITY.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LEVOTHYROXINE versus THYQUIDITY.
Levothyroxine vs THYQUIDITY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Levothyroxine is a synthetic form of thyroxine (T4) that is converted to triiodothyronine (T3) in peripheral tissues. T3 binds to thyroid hormone receptors in the nucleus, regulating gene transcription and increasing metabolic rate, protein synthesis, and oxygen consumption.
Thyroid hormone replacement; levothyroxine (T4) is deiodinated to triiodothyronine (T3), which binds to thyroid hormone receptors, regulating gene transcription and increasing metabolic rate.
1.6 mcg/kg orally once daily, adjusted based on TSH levels; typical adult dose 50-200 mcg/day.
50 mg orally once daily, with or without food.
None Documented
None Documented
7 days (euthyroid); prolonged in hyperthyroidism (3-4 days) and shortened in hypothyroidism (9-10 days); clinical effects persist for weeks after discontinuation due to slow elimination.
Clinical Note
moderateLevothyroxine + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Levothyroxine."
Clinical Note
moderateLevothyroxine + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Levothyroxine."
Clinical Note
moderateLevothyroxine + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Levothyroxine."
Clinical Note
moderateLevothyroxine + Fluconazole
The terminal elimination half-life of levothyroxine is approximately 6-7 days in euthyroid individuals. In hyperthyroidism, half-life decreases to 3-4 days; in hypothyroidism, it can extend to 9-10 days. This long half-life supports once-daily dosing and allows for steady-state achievement in about 6-8 weeks.
Primarily renal (approximately 50% as unchanged drug and metabolites, mainly glucuronide and sulfate conjugates); minor biliary/fecal excretion (<20%).
Thyquidity (levothyroxine sodium) is primarily excreted via the kidneys as unchanged drug and metabolites. Approximately 20-40% of an oral dose is excreted in feces via biliary elimination, with the remainder eliminated renally. Up to 80% of an administered dose appears in urine as thyroxine and its metabolites, primarily glucuronide and sulfate conjugates.
Category A/B
Category C
Thyroid Hormone
Thyroid Hormone
"The metabolism of Fluconazole can be decreased when combined with Levothyroxine."